1.73 (-%)
As of Apr 10, 2024
Source:
Eiger Biopharmaceuticals, Inc is a commercial-stage biopharmaceutical company focused on the development of innovative therapies to treat and cure Hepatitis Delta Virus (HDV) and other serious diseases. All five of our rare disease programs have FDA Breakthrough Therapy Designation.
| Country | United States |
| Headquarters | palo alto, california |
| Phone Number | 650-279-9845 |
| Industry | manufacturing |
| CEO | David Apelian |
| Website | www.eigerbio.com |